These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 8025285

  • 1. Effects of BCL-2 antisense oligodeoxynucleotides on in vitro proliferation and survival of normal marrow progenitors and leukemic cells.
    Campos L, Sabido O, Rouault JP, Guyotat D.
    Blood; 1994 Jul 15; 84(2):595-600. PubMed ID: 8025285
    [Abstract] [Full Text] [Related]

  • 2. Antisense-mediated inhibition of BCL2 protooncogene expression and leukemic cell growth and survival: comparisons of phosphodiester and phosphorothioate oligodeoxynucleotides.
    Reed JC, Stein C, Subasinghe C, Haldar S, Croce CM, Yum S, Cohen J.
    Cancer Res; 1990 Oct 15; 50(20):6565-70. PubMed ID: 2208117
    [Abstract] [Full Text] [Related]

  • 3. Normal and leukemic hematopoietic cells manifest differential sensitivity to inhibitory effects of c-myb antisense oligodeoxynucleotides: an in vitro study relevant to bone marrow purging.
    Calabretta B, Sims RB, Valtieri M, Caracciolo D, Szczylik C, Venturelli D, Ratajczak M, Beran M, Gewirtz AM.
    Proc Natl Acad Sci U S A; 1991 Mar 15; 88(6):2351-5. PubMed ID: 2006173
    [Abstract] [Full Text] [Related]

  • 4. c-kit expression by CD34+ bone marrow progenitors and inhibition of response to recombinant human interleukin-3 following exposure to c-kit antisense oligonucleotides.
    Catlett JP, Leftwich JA, Westin EH, Grant S, Huff TF.
    Blood; 1991 Dec 15; 78(12):3186-91. PubMed ID: 1720696
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of in vitro proliferation of chronic myelogenous leukemia progenitor cells by c-myb antisense oligodeoxynucleotides.
    Szczylik C, Skórski T, Malaguarnera L, Hetman J, Chen ST, Calabretta B.
    Folia Histochem Cytobiol; 1996 Dec 15; 34(3-4):129-34. PubMed ID: 8967957
    [Abstract] [Full Text] [Related]

  • 6. Interleukin-10 increases Bcl-2 expression and survival in primary human CD34+ hematopoietic progenitor cells.
    Weber-Nordt RM, Henschler R, Schott E, Wehinger J, Behringer D, Mertelsmann R, Finke J.
    Blood; 1996 Oct 01; 88(7):2549-58. PubMed ID: 8839847
    [Abstract] [Full Text] [Related]

  • 7. Oligodeoxynucleotides antisense to c-abl specifically inhibit entry into S-phase of CD34+ hematopoietic cells and their differentiation to granulocyte-macrophage progenitors.
    Rosti V, Bergamaschi G, Lucotti C, Danova M, Carlo-Stella C, Locatelli F, Tonon L, Mazzini G, Cazzola M.
    Blood; 1995 Nov 01; 86(9):3387-93. PubMed ID: 7579442
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of bcl-2 with antisense oligonucleotides induces apoptosis and increases the sensitivity of AML blasts to Ara-C.
    Keith FJ, Bradbury DA, Zhu YM, Russell NH.
    Leukemia; 1995 Jan 01; 9(1):131-8. PubMed ID: 7845007
    [Abstract] [Full Text] [Related]

  • 9. Antisense oligodeoxynucleotides to bax mRNA promote survival of rat sympathetic neurons in culture.
    Gillardon F, Zimmermann M, Uhlmann E, Krajewski S, Reed JC, Klimaschewski L.
    J Neurosci Res; 1996 Mar 15; 43(6):726-34. PubMed ID: 8984202
    [Abstract] [Full Text] [Related]

  • 10. Stem cell factor as a survival and growth factor in human normal and malignant hematopoiesis.
    Hassan HT, Zander A.
    Acta Haematol; 1996 Mar 15; 95(3-4):257-62. PubMed ID: 8677752
    [Abstract] [Full Text] [Related]

  • 11. Liposomal Bcl-2 antisense oligonucleotides enhance proliferation, sensitize acute myeloid leukemia to cytosine-arabinoside, and induce apoptosis independent of other antiapoptotic proteins.
    Konopleva M, Tari AM, Estrov Z, Harris D, Xie Z, Zhao S, López-Berestein G, Andreeff M.
    Blood; 2000 Jun 15; 95(12):3929-38. PubMed ID: 10845930
    [Abstract] [Full Text] [Related]

  • 12. In vivo treatment of human leukemia in a scid mouse model with c-myb antisense oligodeoxynucleotides.
    Ratajczak MZ, Kant JA, Luger SM, Hijiya N, Zhang J, Zon G, Gewirtz AM.
    Proc Natl Acad Sci U S A; 1992 Dec 15; 89(24):11823-7. PubMed ID: 1281545
    [Abstract] [Full Text] [Related]

  • 13. The effect of c-raf antisense oligonucleotides on growth factor-induced proliferation of hematopoietic cells.
    Keller JR, Ruscetti FW, Heidecker G, Linnekin DM, Rapp U, Troppmair J, Gooya J, Muszynski KW.
    Curr Top Microbiol Immunol; 1996 Dec 15; 211():43-53. PubMed ID: 8585963
    [Abstract] [Full Text] [Related]

  • 14. Oligodeoxynucleotides antisense to the proto-oncogene c-mpl specifically inhibit in vitro megakaryocytopoiesis.
    Methia N, Louache F, Vainchenker W, Wendling F.
    Blood; 1993 Sep 01; 82(5):1395-401. PubMed ID: 7689867
    [Abstract] [Full Text] [Related]

  • 15. Effects of BCR-ABL antisense oligonucleotides (AS-ODN) on human chronic myeloid leukemic cells: AS-ODN as effective purging agents.
    Wu AG, Joshi SS, Chan WC, Iversen PL, Jackson JD, Kessinger A, Pirruccello SJ, Sanger WG, Sharp JG, Verbik DJ.
    Leuk Lymphoma; 1995 Dec 01; 20(1-2):67-76. PubMed ID: 8750625
    [Abstract] [Full Text] [Related]

  • 16. Flt3 ligand stimulates proliferation and inhibits apoptosis of acute myeloid leukemia cells: regulation of Bcl-2 and Bax.
    Lisovsky M, Estrov Z, Zhang X, Consoli U, Sanchez-Williams G, Snell V, Munker R, Goodacre A, Savchenko V, Andreeff M.
    Blood; 1996 Nov 15; 88(10):3987-97. PubMed ID: 8916965
    [Abstract] [Full Text] [Related]

  • 17. c-abl function in normal and chronic myelogenous leukemia hematopoiesis: in vitro studies with antisense oligomers.
    Rosti V, Bergamaschi G, Ponchio L, Cazzola M.
    Leukemia; 1992 Jan 15; 6(1):1-7. PubMed ID: 1736009
    [Abstract] [Full Text] [Related]

  • 18. [Design of antisense oligodeoxynucleotide targeting at bcl-2 mRNA and observation on its effect on the sensitivity of leukemia cells to arabinosyl cytosine].
    Lei XY, Zhang Y.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Feb 15; 11(1):41-4. PubMed ID: 12667288
    [Abstract] [Full Text] [Related]

  • 19. Raf-1 protein is required for growth factor-induced proliferation of hematopoietic cells.
    Muszynski KW, Ruscetti FW, Heidecker G, Rapp U, Troppmair J, Gooya JM, Keller JR.
    J Exp Med; 1995 Jun 01; 181(6):2189-99. PubMed ID: 7539043
    [Abstract] [Full Text] [Related]

  • 20. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
    Drexler HG.
    Leukemia; 1996 Apr 01; 10(4):588-99. PubMed ID: 8618433
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.